FHD-286
|
|
- CAS号:
- 2671128-05-3
- 英文名:
- FHD-286
- 英文别名:
- FHD-286;Inhibitor,inhibit,FHD 286,FHD-286,Epigenetic Reader Domain,FHD286;N-[(S)-1-[[4-[6-[(2R,6S)-2,6-Dimethylmorpholino]-2-pyridyl]-2-thiazolyl]amino]-3-methoxy-1-oxo-2-propyl]-1-(methylsulfonyl)-1H-pyrrole-3-carboxamide;N-[(1S)-2-[[4-[6-[cis-2,6-dimethylmorpholin-4-yl]-2-pyridyl]thiazol-2-yl]amino]-1-(methoxymethyl)-2-oxo-ethyl]-1-methylsulfonyl-pyrrole-3-carboxamide;N-[(2S)-1-[[4-[6-[(2S,6R)-2,6-dimethyl-4-morpholinyl]-2-pyridinyl]-2-thiazolyl]amino]-3-methoxy-1-oxopropan-2-yl]-1-methylsulfonyl-3-pyrrolecarboxamide;1H-Pyrrole-3-carboxamide, N-[(1S)-2-[[4-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-2-pyridinyl]-2-thiazolyl]amino]-1-(methoxymethyl)-2-oxoethyl]-1-(methylsulfonyl)-
- 中文名:
- FHD-286
- 中文别名:
- 化合物FHD-286;N-[(S)-1-[[4-[6-[(2R,6S)-2,6-二甲基(4-吗啉基)]-2-吡啶基]-2-噻唑基]氨基]-3-甲氧基-1-氧代-2-丙基]-1-(甲砜基)-1H-吡咯-3-甲酰胺;N-[(1S)-2-[[4-[6-[(2R,6S)-2,6-二甲基-4-吗啉基]-2-吡啶基]-2-噻唑基]氨基]-1-(甲氧基甲基)-2-氧代乙基]-1-(甲基磺酰基)-1H-吡咯-3-甲酰胺;N-((S)-1-((4-(6-(CIS-2,6-DIMETHYLMORPHOLINO)PYRIDIN-2-YL)THIAZOL-2-YL)AMINO)-3-METHOXY-1-OXOPROPAN-2
- CBNumber:
- CB410298404
- 分子式:
- C24H30N6O6S2
- 分子量:
- 562.66
- MOL File:
- 2671128-05-3.mol
|
|
|
FHD-286化学性质
-
密度:
-
1.46±0.1 g/cm3(Predicted)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
DMSO : 250 mg/mL (444.32 mM; Need ultrasonic)
-
|
-
形态:
-
Solid
-
|
-
酸度系数(pKa):
-
7.18±0.50(Predicted)
-
|
-
颜色:
-
Off-white to light yellow
-
|
-
InChIKey:
-
JBLQNFBXKOAIHG-FCEWJHQRSA-N
-
|
-
SMILES:
-
N1(S(C)(=O)=O)C=CC(C(N[C@@H](COC)C(NC2=NC(C3=NC(N4C[C@H](C)O[C@H](C)C4)=CC=C3)=CS2)=O)=O)=C1
-
|
FHD-286性质、用途与生产工艺
FHD-286是BRM/BRG1 ATPase 的抑制剂,可用于治疗BAF相关疾病如急性髓性白血病的研究。
FHD-286
上下游产品信息
上游原料
下游产品
更新日期 | 产品编号 | 产品名称 | CAS编号 | 包装 | 价格 |
---|
2024/04/30 | HY-144835 | FHD-286 | | 1 mg | 1800元 |
2024/04/30 | HY-144835 | FHD-286 FHD-286 | 2671128-05-3 | 5 mg | 3700元 |
2671128-05-3, FHD-286 相关搜索:
- 标准品
- 医药原料
- C24H30N6O6S2
- 671128-05-3
- N-[(1S)-2-[[4-[6-[(2R,6S)-2,6-二甲基-4-吗啉基]-2-吡啶基]-2-噻唑基]氨基]-1-(甲氧基甲基)-2-氧代乙基]-1-(甲基磺酰基)-1H-吡咯-3-甲酰胺
- N-[(S)-1-[[4-[6-[(2R,6S)-2,6-二甲基(4-吗啉基)]-2-吡啶基]-2-噻唑基]氨基]-3-甲氧基-1-氧代-2-丙基]-1-(甲砜基)-1H-吡咯-3-甲酰胺
- 化合物FHD-286
- N-((S)-1-((4-(6-(CIS-2,6-DIMETHYLMORPHOLINO)PYRIDIN-2-YL)THIAZOL-2-YL)AMINO)-3-METHOXY-1-OXOPROPAN-2
- 2671128-05-3
- N-[(2S)-1-[[4-[6-[(2S,6R)-2,6-dimethyl-4-morpholinyl]-2-pyridinyl]-2-thiazolyl]amino]-3-methoxy-1-oxopropan-2-yl]-1-methylsulfonyl-3-pyrrolecarboxamide
- N-[(S)-1-[[4-[6-[(2R,6S)-2,6-Dimethylmorpholino]-2-pyridyl]-2-thiazolyl]amino]-3-methoxy-1-oxo-2-propyl]-1-(methylsulfonyl)-1H-pyrrole-3-carboxamide
- N-[(1S)-2-[[4-[6-[cis-2,6-dimethylmorpholin-4-yl]-2-pyridyl]thiazol-2-yl]amino]-1-(methoxymethyl)-2-oxo-ethyl]-1-methylsulfonyl-pyrrole-3-carboxamide
- Inhibitor,inhibit,FHD 286,FHD-286,Epigenetic Reader Domain,FHD286
- FHD-286
- 1H-Pyrrole-3-carboxamide, N-[(1S)-2-[[4-[6-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-2-pyridinyl]-2-thiazolyl]amino]-1-(methoxymethyl)-2-oxoethyl]-1-(methylsulfonyl)-